Author:
Hasegawa Takahiro,Claggett Brian,Tian Lu,Solomon Scott D.,Pfeffer Marc A.,Wei Lee-Jen
Funder
National Heart, Lung, and Blood Institute
National Institute of General Medical Sciences
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Biochemistry, Genetics and Molecular Biology (miscellaneous),Statistics and Probability
Reference21 articles.
1. Taylor F, Huffman MD, Macedo AF, Moore THM, Burke M, Davey Smith G et al (2013) Statins for the primary prevention of cardiovascular disease. Cochrane Libr 1:348
2. Abrams KR, Jones DR, Jones DR, Sheldon TA, Song F (2000) Methods for meta-analysis in medical research. Wiley, New York
3. Normand SLT (1999) Tutorial in biostatistics meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 18:321–359
4. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ et al (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364:685–696
5. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM Jr., Kastelein JJ et al, JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献